Newborn Pain and Stress Levels in Oxytocin Induction at Birth
The Effect of Using Oxytocin Induction at Birth on Neonatal Pain and Stress.
1 other identifier
interventional
164
1 country
1
Brief Summary
The aim of the study is to compare pain and stress levels in the early neonatal period in newborns with and without oxytocin induction. The research was conducted in a case-control study design. The population of the study consisted of participants who gave birth vaginally (with or without oxytocin induction). The sample number of the study was calculated with the G\*Power 3.1.9.2 program, taking into account the mean and standard deviation values of the NIPS score in Cetinkaya et al., (2020). Effect size: 0.666, α= 0.05, power: 0.95, oxytocin induction group: 60, non-oxytocin induction group: 60. Anticipating possible data loss, 164 participants and their newborns were included, 85 in the oxytocin induction group and 79 in the non-oxytocin induction group. was included. The data of the study were collected using the Pregnant Information Form, Neonatal Follow-up Form and Newborn Pain and Stress Assessment Scale (ALPS-Neo). The research data were analyzed in SPSS 29.0 (IBM) program.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 20, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 10, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 10, 2023
CompletedFirst Submitted
Initial submission to the registry
June 19, 2024
CompletedFirst Posted
Study publicly available on registry
June 25, 2024
CompletedJune 25, 2024
June 1, 2024
11 months
June 19, 2024
June 19, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Filling out the ALPS-Neo form before the newborn drying procedure.
ALPS-Neo form was completed before the newborn drying procedure.
In the first minute after birth.
Filling in the ALPS-Neo form during the newborn drying process.
ALPS-Neo form was filled out during the newborn drying process.
At 5 minutes after birth.
Filling out the ALPS-Neo form after the newborn drying procedure.
ALPS-Neo form was completed after the newborn drying procedure.
At the 5th minute after drying.
Secondary Outcomes (3)
Completion of the ALPS-Neo form before the first injection procedure in the newborn.
At 15 minutes after birth.
Completion of the ALPS-Neo form during the first injection procedure in the newborn.
At 20 minutes after birth.
Completion of the ALPS-Neo form after the first injection procedure in the newborn.
At 5 minutes after the first injection.
Other Outcomes (3)
Filling out the ALPS-Neo form before the newborn blood glucose measurement procedure.
At 30 minutes after birth.
Filling in the ALPS-Neo form during the neonatal blood glucose measurement procedure.
At 35 minutes after birth.
Filling out the ALPS-Neo form after the newborn blood glucose measurement procedure.
At the 5th minute after blood glucose measurement.
Study Arms (2)
Oxytocin induction group
ACTIVE COMPARATORParticipants in the oxytocin induction group received oxytocin induction during labour. The ALPS-Neo form was completed between 1-40 minutes after delivery, based on observation before, during and after the drying process, the first injection process and the blood glucose measurement procedures.
Control group
ACTIVE COMPARATORParticipants in the control group did not receive oxytocin induction during labour. The ALPS-Neo form was completed between 1-40 minutes after delivery, based on observation before, during and after the drying process, the first injection procedure and the blood glucose measurement procedures.
Interventions
Participants in the oxytocin induction group filled out the "Information Form" at the time of application to the delivery room. Routine care was performed. ALPS-Neo was filled before, during and at 5 minutes after the drying of the newborn within 1-40 minutes after birth. ALPS-Neo was filled before, during and 5 minutes after the first injection. ALPS-Neo was filled before, during and 5 minutes after the blood glucose measurement procedure.
Participants in the control group filled in the "Information Form" when they applied to the birth centre. Routine care was performed. ALPS-Neo was filled before, during and at 5 minutes after the drying of the newborn within 1-40 minutes after birth. ALPS-Neo was filled before, during and 5 minutes after the first injection. ALPS-Neo was filled before, during and 5 minutes after the blood glucose measurement procedure.
Eligibility Criteria
You may qualify if:
- Pregnant at term,
- Giving birth vaginally,
- Birth weight ≥2500gr,
- Participants with a single and healthy fetus and their newborns
You may not qualify if:
- Mentally incompetent,
- Having a high-risk pregnancy,
- Those with risky newborns
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kocaeli University
Kocaeli, 41380, Turkey (Türkiye)
Related Publications (1)
Cetinkaya S, Yavas Celik M, Ozdemir S. Effect of white noise on alleviating the pain of new-born during invasive procedures. J Matern Fetal Neonatal Med. 2022 Apr;35(8):1426-1432. doi: 10.1080/14767058.2020.1755652. Epub 2020 Apr 21.
PMID: 32316794BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sena Dilek Aksoy, Ph.D.
Kocaeli University
- STUDY CHAIR
Seda Yazici Yel, M.Sc.
Darica Farabi Training and Research Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 19, 2024
First Posted
June 25, 2024
Study Start
January 20, 2023
Primary Completion
December 10, 2023
Study Completion
December 10, 2023
Last Updated
June 25, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will not share